UBS Group AG - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 32 filers reported holding VASCULAR BIOGENICS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q3 2023$13
-96.1%
53
-98.1%
0.00%
Q4 2022$334
-96.7%
2,784
-95.7%
0.00%
Q3 2022$10,000
+900.0%
64,923
+15140.1%
0.00%
Q1 2022$1,000
-80.0%
426
-81.8%
0.00%
Q4 2021$5,000
+400.0%
2,336
+563.6%
0.00%
Q3 2021$1,000
-94.1%
352
-95.1%
0.00%
Q2 2021$17,000
+1600.0%
7,150
+891.7%
0.00%
Q2 2020$1,000
-83.3%
721
-84.3%
0.00%
Q1 2020$6,000
+500.0%
4,600
+320.1%
0.00%
Q4 2019$1,000
-66.7%
1,095
-54.8%
0.00%
Q3 2019$3,000
-57.1%
2,422
-67.6%
0.00%
Q4 2018$7,0000.0%7,483
+71.2%
0.00%
Q3 2018$7,0000.0%4,372
+337.2%
0.00%
Q4 2017$7,000
+16.7%
1,0000.0%0.00%
Q3 2017$6,000
+50.0%
1,0000.0%0.00%
Q2 2017$4,000
-60.0%
1,000
-45.7%
0.00%
Q3 2016$10,000
+150.0%
1,842
+191.0%
0.00%
Q2 2015$4,000
-50.0%
633
-58.1%
0.00%
Q1 2015$8,000
-42.9%
1,512
-34.7%
0.00%
Q4 2014$14,0002,3160.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Lion Point Capital, LP 2,593,286$4,382,0001.02%
Telemetry Investments, L.L.C. 75,000$127,0000.20%
Ikarian Capital, LLC 830,747$1,404,0000.18%
DLD Asset Management, LP 550,000$930,0000.06%
Phoenix Holdings Ltd. 1,020,000$1,724,0000.03%
Spectrum Planning & Advisory Services Inc. 16,000$27,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 79,716$135,0000.00%
HBK Sorce Advisory LLC 22,325$38,0000.00%
B. Riley Wealth Management, Inc. 12,000$20,0000.00%
TWO SIGMA SECURITIES, LLC 12,155$21,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders